Parallel Overview

  • Founded

  • 2014

Founded
  • Status

  • Private

  • Employees

  • 1,700

Employees
  • Latest Deal Type

  • Later Stage VC

  • Latest Deal Amount

  • $43.3M

  • Investors

  • 9

Parallel General Information

Description

Producer of cannabis-based medical products intended to empower health and well-being. The company's offerings include a diverse portfolio of proprietary brands that are made available in a variety of footprints including flower, pre-rolls, vaporizer pens, tinctures, oral sprays, topical creams, time-released transdermal patches, soft gels and cannabis-infused products, enabling consumers to improve the quality of lives through the benefits of cannabinoids.

Contact Information

Website
www.liveparallel.com
Formerly Known As
SH NewCo, Surterra Wellness, SH Parent
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Specialty Retail
Other Industries
Other Consumer Non-Durables
Internet Retail
Primary Office
  • 55 Ivan Allen Boulevard
  • Suite 900
  • Atlanta, GA 30308
  • United States

Parallel Timeline

2020202120222023
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Parallel Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
11. Later Stage VC 01-Nov-2021 $43.3M 00000 Completed Profitable
10. Reverse Merger 22-Feb-2021 00.00 Cancelled Profitable
9. PIPE 30-Sep-2021 00000 Cancelled Profitable
8. Debt Refinancing 07-May-2021 00000 00000 Completed Profitable
7. Debt - General 00000 Completed Profitable
6. Later Stage VC (Series E) 15-Feb-2021 0000 00000 Completed Profitable
5. Later Stage VC (Series D) 27-Jun-2019 00000 00000 00.000 Completed Generating Revenue
4. Later Stage VC (Series C) 06-Aug-2018 0000 0000 00000 Completed Generating Revenue
3. Early Stage VC (Series BB) 25-Sep-2017 $7M $31M 000.00 Completed Generating Revenue
2. Early Stage VC (Series B) 11-Dec-2016 $15M $24M 000.00 Completed Generating Revenue
To view Parallel’s complete valuation and funding history, request access »

Parallel Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series C 00,000,000 00.000000 00 00.00 00.00 00 00.00 00.00
Series B 00,000,000 00.000000 000 00.00 00.00 00 00.00 00.000
Series BB 0,000,000 00.000000 000 00.00 00.00 00 00.00 0.00
Series A-4 000,000 00.000000 00.00 00.00 00 00.00 0.000
Series A-3 00,000 00.000000 00.00 00.00 00 00.00 0.000
Series A-2 604,100 $0.001000 $1.74 $1.74 1x $1.38 1.54%
Series A-1 370,000 $0.001000 $0.5 $0.5 1x $0.5 0.75%
To view Parallel’s complete cap table history, request access »

Parallel Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Producer of cannabis-based medical products intended to empower health and well-being. The company's offerings include a
Specialty Retail
Atlanta, GA
1,700 As of 2021
00000
0000000000 0 00000

000000

dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco
00000 00000000000000
Chicago, IL
0000 As of 0000
00000
0000000000 0 00000

000000

iquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in volupta
00000 00000000 000-0
New York, NY
0000 As of 0000
00000
0000 0000-00-00
000000&0 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Parallel Competitors (7)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
PharmaCann Venture Capital-Backed Chicago, IL 0000 00000 0000000000 0 00000
0000000 00000000 Formerly PE-Backed New York, NY 0000 00000 000000&0 00000
00000000 00000000 Corporate Backed or Acquired Quincy, FL 0000 00000 000000&0 00000
00000 00000 000000 Corporation Chicago, IL 0000 00000 000000000 00000
000000 0000 Formerly VC-backed Chicago, IL 0000 00000 000000000 00000
You’re viewing 5 of 7 competitors. Get the full list »

Parallel Executive Team (19)

Name Title Board Seat Contact Info
Karim Bouaziz President
Barry Jones Chief Financial Officer
Phil Harris Chief Legal Counsel & Board Member
James Whitcomb Chief Executive Officer & Board Member
You’re viewing 4 of 19 executive team members. Get the full list »

Parallel Board Members (16)

Name Representing Role Since
James Whitcomb Self Chief Executive Officer & Board Member 000 0000
Jason Becker Parallel Board Member 000 0000
Joe Crouthers Self Board Member 000 0000
Kevin Douglas Self Board Member 000 0000
Linda McGoldrick Self Board Member 000 0000
You’re viewing 5 of 16 board members. Get the full list »

Parallel Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Parallel Investors (9)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
G5 Capital (Greenwich) Venture Capital Minority 000 0000 000000 0
StartX (US) Not-For-Profit Venture Capital Minority 000 0000 000000 0
LFG Ventures (VC) Venture Capital Minority 000 0000 000000 0
Patrón Tequila Other Minority 000 0000 000000 0
Poseidon Asset Management Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 9 investors. Get the full list »

Parallel Investments & Acquisitions (5)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000000 (00000 16-Mar-2022 0000 00000 0000 Financial Software
00000 0000000 30-Sep-2021 0000000000 Special Purpose Acquisition Company (SPAC)
000000000 000 25-Jun-2019 0000000000 Drug Discovery 0000000 0
000 0000000 0 21-Jun-2019 0000000000 Other Healthcare Services 0000000 0
The Apothecary Shoppe (Las Vegas) 11-Dec-2018 Merger/Acquisition Pharmaceuticals 0000000 0
To view Parallel’s complete investments and acquisitions history, request access »

Ready to get started?

Request a free trial

Parallel Subsidiaries (2)

Company Name Industry Location Founded
Molecular Infusions Drug Discovery Franklin, MA 2016
000 0000000 000000 Other Healthcare Services Brookline, MA 0000
To view Parallel’s complete subsidiaries history, request access »